Smoking clinical trials
Access comprehensive clinical trial information for Smoking through Pure Global AI's free database. This collection includes 309 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 19 trials are actively recruiting participants.
Research for Smoking is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include Philip Morris Products S.A. and The University of Hong Kong. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 309 clinical trials studying Smoking, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Philip Morris Products S.A., The University of Hong Kong, Yale University, among others.